Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease

BACKGROUND: The Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) is a 10-item patient-reported outcome (PRO) measure designed to assess the severity of mitochondrial disease symptoms. Analyses of data from a clinical trial with PMM patients were conducted to evaluate the psychometric proper...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwaltney, Chad, Stokes, Jonathan, Aiudi, Anthony, Mazar, Iyar, Ollis, Sarah, Love, Emily, Karaa, Amel, Houts, Carrie R., Wirth, R. J., Shields, Alan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789285/
https://www.ncbi.nlm.nih.gov/pubmed/36562873
http://dx.doi.org/10.1186/s41687-022-00534-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789285/
https://www.ncbi.nlm.nih.gov/pubmed/36562873
http://dx.doi.org/10.1186/s41687-022-00534-y

Ejemplares similares